Y
Young Baek
Researcher at National Institutes of Health
Publications - 3
Citations - 217
Young Baek is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Amyloid beta & Dementia. The author has an hindex of 3, co-authored 3 publications receiving 157 citations.
Papers
More filters
Journal ArticleDOI
A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank
Jon B. Toledo,Vivianna M. Van Deerlin,Edward B. Lee,EunRan Suh,Young Baek,John L. Robinson,Sharon X. Xie,Jennifer D. McBride,Elisabeth M. Wood,Theresa Schuck,David J. Irwin,Rachel G. Gross,Howard I. Hurtig,Leo McCluskey,Lauren Elman,Jason Karlawish,Gerard D. Schellenberg,Alice Chen-Plotkin,David A. Wolk,Murray Grossman,Steven E. Arnold,Leslie M. Shaw,Virginia M.-Y. Lee,John Q. Trojanowski +23 more
TL;DR: This work describes a biobanking system that is a platform for discovery research at the Center for Neurodegenerative Disease Research at the University of Pennsylvania and describes a flexible and user‐friendly database system that facilitates the sharing of information of all the teams in the network.
Journal ArticleDOI
Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study.
Yuk Yee Leung,Jon B. Toledo,Alexey Nefedov,Robi Polikar,Nandini Raghavan,Sharon X. Xie,Michael Farnum,Tim Schultz,Young Baek,Vivianna M. Van Deerlin,William T. Hu,David M. Holtzman,Anne M. Fagan,Richard J. Perrin,Murray Grossman,Holly Soares,Mitchel A. Kling,Matthew D. Mailman,Steven E. Arnold,Vaibhav A. Narayan,Virginia M.-Y. Lee,Leslie M. Shaw,David L. Baker,Gayle M. Wittenberg,John Q. Trojanowski,Li-San Wang +25 more
TL;DR: In this paper, the dynamic range of cerebrospinal fluid (CSF) amyloid β (Aβ1−42) measurement does not parallel to cognitive changes in Alzheimer's disease (AD) and cognitively normal (CN) subjects across different studies.
Journal Article
Identifying amyloid pathology-related cerebrospinal fluid biomarkers for Alzheimer's disease in a multicohort study
Yuk Yee Leung,Jon B. Toledo,Alexey Nefedov,Robi Polikar,Nandini Raghavan,Sharon X. Xie,Michael Farnum,Tim Schultz,Young Baek,Vivianna M. Van Deerlin,William T. Hu,David M. Holtzman,Anne M. Fagan,Richard J. Perrin,Murray Grossman,Holly Soares,Mitchel A. Kling,Matthew D. Mailman,Steven E. Arnold,Vaibhav A. Narayan,Virginia M.-Y. Lee,Leslie M. Shaw,David L. Baker,Gayle M. Wittenberg,John Q. Trojanowski,Li-San Wang +25 more
TL;DR: The dynamic range of cerebrospinal fluid (CSF) amyloid β (Aβ1–42) measurement does not parallel to cognitive changes in Alzheimer's disease and cognitively normal subjects across different studies, so identifying novel proteins to characterize symptomatic AD samples is important.